成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國(guó)籍:中國(guó)
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11973
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

Br-PEG4-THP 1803547-60-5
Fentiazac 18046-21-4
YNT-185 1804978-81-1
YNT-185 dihydrochloride 1804978-82-2
FM04 1807320-40-6
IACS-010759 hydrochloride 1807523-99-4
TBDMS-PEG4-Acid 1807540-77-7
CJJ300 1807631-83-9
Gedivumab 1807954-17-1
Lesofavumab 1807960-57-1
Gilvetmab 1808081-43-7
Linvencorvir 1808248-05-6
Resomelagon 1809420-71-0
NS1-IN-1 181373-35-3
NTRC 0066-0 1817791-73-3
TAK-418 1818252-53-7
Anticonvulsant agent 10 HCl 1818253-48-3
Cis-22a 1819366-84-1
GlyT1 Inhibitor 1 1820934-93-7
Lorundrostat 1820940-17-7
ZY-19489 1821293-40-6
Tinlarebant 1821327-95-0
N-Nitroso-N-methylaniline-d5 1821341-18-7
BRD2492 1821669-43-5
SMO-IN-2 1822355-27-0
SDH-IN-2 1823354-06-8
Acloproxalap 1824609-67-7
TRV-120027 acetate (1234510-46-3 free base) 1824712-70-0
CXCR2 antagonist 8 182498-30-2
Smurf-1 modulator CMP Example 20 1825371-51-4
Gatralimab 1826020-80-7
Azintuxizumab 1826819-57-1
Talacotuzumab 1826831-79-1
cPrPMEDAP 182798-83-0
Clenoliximab 182912-58-9
Idelalisib D5 1830330-31-8
Duvortuxizumab 1831098-91-9
Lacnotuzumab 1831128-32-5
MLT-985 1832576-25-6
L-161240 183298-68-2
Gantofiban 183547-57-1
EGFR-IN-87 1835666-87-9
Rezivertinib 1835667-12-3
AY 77 1835734-92-3
CXCR2-IN-2 1838123-21-9
NS-2710 184220-36-8
NBI-27914 184241-44-9
Cofrogliptin 1844874-26-5
(Iso)-Rilmakalim 184653-89-2
Diprogulic acid 18467-77-1
Setrusumab 1847394-95-9
Tibulizumab 1849636-24-3
Zavondemstat 1851412-93-5
PF-06649298 1854061-16-7
PF-06761281 1854061-19-0
Trifluoromethyl-tubercidin 1854086-05-7
Iruplinalkib 1854943-32-0
Cibisatamab 1855925-27-7
Tislelizumab 1858168-59-8
Basroparib 1858179-75-5
Edralbrutinib 1858206-58-2
(3S,4S)-PF-06459988 1858291-14-1
Tofimilast 185954-27-2
Tyrosinase-IN-12 1860779-42-5
STC314 186295-19-2
hCYP3A4 Fluorogenic substrate 1 186299-00-3
PF-06737007 1863905-38-7
SU 5616 186611-58-5
TriGalNAc CBz 186613-57-0
Berberine ursodeoxycholate 1868138-66-2
Cofetuzumab 1869928-62-0
(R)-CJ 11974 187281-35-2
Loncastuximab 1875032-68-0
Naxitamab 1879925-92-4
FFN 206 dihydrochloride 1883548-88-6
JTV-519 fumarate 1883549-36-7
OPC-167832 1883747-71-4
Mirikizumab 1884201-71-1
HDAC8-IN-20a 1884231-52-0
Cbz-B3A 1884710-81-9
EM127 1886879-71-5
PB1 188714-28-5
EPZ032597 1887193-58-9
EPZ033294 1887195-17-6
Dersalazine 188913-58-8
HS94 1892594-93-2
Tisolagiline 1894207-44-3
Omburtamab 1895083-75-6
MMPP 1895957-18-2
Aplindore Fumarate 189681-71-8
Zamaporvint 1900754-56-4
Fmoc-aminooxy-PEG2-NH2 190249-87-7
1,4-Dideoxy-1,4-epithio-D-ribitol 190315-43-6
Mosunetuzumab 1905409-39-3
Iladatuzumab 1906205-76-2
Enapotamab 1912423-61-0
Ursolic aldehyde 19132-81-1
Propionic-2,2-d2 acid 19136-91-5
3-phenylpropanoic-2,2-d2 acid 19136-97-1
Ezurpimtrostat hydrochloride 1914148-73-4
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.